MonoPlus® in Orthopedic Surgery

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

January 18, 2022

Primary Completion Date

July 7, 2023

Study Completion Date

July 7, 2024

Conditions
Orthopedic SurgerySoft Tissue Approximation
Interventions
DEVICE

MonoPlus®

MonoPlus® is indicated for use in general soft tissue approximation, specially in cases where extended wound support of more than 4 weeks is desirable

Trial Locations (1)

28007

Hospital Gregorio Marañón, Madrid

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

B.Braun Surgical SA

INDUSTRY

lead

Aesculap AG

INDUSTRY

NCT05257278 - MonoPlus® in Orthopedic Surgery | Biotech Hunter | Biotech Hunter